The global point-of-care molecular diagnostics market size is anticipated to reach US$ 6.50 Billion by 2028 increasing at a CAGR of 14.4% in the given forecast period.
Ongoing research & development to miniaturize molecular diagnostics testing that provides increased near patient testing with high accuracy and lesser turnaround times are major factors expected to reinforce the high growth potential for POC products. Molecular testing enables physicians to improve the standard of care by combining quick diagnosis with treatment decision in the first visit by the patient instead of hours and days to have the test results. This would help order a treatment in the first instance without having to wait for final results.
The global POC Molecular Diagnostics market is segregated on the basis of Application as Infectious Diseases, Oncology, Hematology, Prenatal Testing, and Endocrinology. Based on Technology the global POC Molecular Diagnostics market is segmented in PCR-based, Genetic Sequencing-based, Hybridization-based, and Microarray-based. Based on End Use the global POC Molecular Diagnostics market is segmented in Decentralized Labs, Hospitals, Homecare, and Assisted Living Healthcare Facilities.
The global POC Molecular Diagnostics market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The POC Molecular Diagnostics market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Johnson & Johnson, Danaher Corp, Cepheid, Inc, Bio-Rad Laboratories, Inc, biomatrix, Becton, Dickinson and Company, Hoffmann-La Roche AG, Bayer HealthCare Pharmaceuticals LLC, and others are among the major players in the global POC Molecular Diagnostics market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The POC Molecular Diagnostics Market has been segmented as below:
POC Molecular Diagnostics Market, By Application
POC Molecular Diagnostics Market, By Technology
POC Molecular Diagnostics Market, By End Use
POC Molecular Diagnostics Market, By Region
POC Molecular Diagnostics Market, By Company
The report covers:
Report Scope:
The global POC Molecular Diagnostics market report scope includes detailed study covering underlying factors influencing the industry trends.
The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.
The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global POC Molecular Diagnostics market share. Major industry players with significant revenue share include Johnson & Johnson, Danaher Corp, Cepheid, Inc, Bio-Rad Laboratories, Inc, biomatrix, Becton, Dickinson and Company, Hoffmann-La Roche AG, Bayer HealthCare Pharmaceuticals LLC, and others.
Reasons to Buy this Report:
Customization
Customized report as per the requirement can be offered with appropriate recommendations
Below are our new reports:
Digital Veterinary Thermometers Market
Digital Breast Tomosynthesis Market
1. Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
2. Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach – Segmental Market Analysis
2.5.2 Top-Down Approach – Parent Market Analysis
3. Executive Summary
4. Market Overview
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter’s Five Force Analysis
5. POC Molecular Diagnostics Market, By Application
5.1 Introduction
5.2 Infectious Diseases
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Oncology
5.3.1 Market Overview
5.3.2 Market Size and Forecast
5.4 Hematology
5.4.1 Market Overview
5.4.2 Market Size and Forecast
5.5 Prenatal Testing
5.5.1 Market Overview
5.5.2 Market Size and Forecast
5.6 Endocrinology
5.6.1 Market Overview
5.6.2 Market Size and Forecast
6. POC Molecular Diagnostics Market, By Technology
6.1 Introduction
6.2 PCR-based
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Genetic Sequencing-based
6.3.1 Market Overview
6.3.2 Market Size and Forecast
6.4 Hybridization-based
6.4.1 Market Overview
6.4.2 Market Size and Forecast
6.5 Microarray-based
6.5.1 Market Overview
6.5.2 Market Size and Forecast
7. POC Molecular Diagnostics Market, By End Use
7.1 Introduction
7.2 Decentralized Labs
7.2.1 Market Overview
7.2.2 Market Size and Forecast
7.3 Hospitals
7.3.1 Market Overview
7.3.2 Market Size and Forecast
7.4 Homecare
7.4.1 Market Overview
7.4.2 Market Size and Forecast
7.5 Assisted Living Healthcare Facilities
7.5.1 Market Overview
7.5.2 Market Size and Forecast
8. POC Molecular Diagnostics Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 North America POC Molecular Diagnostics, By Application
8.2.2 North America POC Molecular Diagnostics, By Technology
8.2.3 North America POC Molecular Diagnostics, By End Use
8.3 Europe
8.3.1 Europe POC Molecular Diagnostics, By Application
8.3.2 Europe POC Molecular Diagnostics, By Technology
8.3.3 Europe POC Molecular Diagnostics, By End Use
8.4 Asia-Pacific
8.4.1 Asia-Pacific POC Molecular Diagnostics, By Application
8.4.2 Asia-Pacific POC Molecular Diagnostics, By Technology
8.4.3 Asia-Pacific POC Molecular Diagnostics, By End Use
8.5 Rest of the World
8.5.1 Rest of the World POC Molecular Diagnostics, By Application
8.5.2 Rest of the World POC Molecular Diagnostics, By Technology
8.5.3 Rest of the World POC Molecular Diagnostics, By End Use
9. Competitive Insights
9.1 Key Insights
9.2 Company Market Share Analysis
9.3 Strategic Outlook
9.3.1 Mergers & Acquisitions
9.3.2 New Product Development
9.3.3 Portfolio/Production Capacity Expansions
9.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
9.3.5 Others
10. Company Profiles
10.1 Johnson & Johnson
10.1.1 Company Overview
10.1.2 Product/Service Landscape
10.1.3 Financial Overview
10.1.4 Recent Developments
10.2 Danaher Corp
10.2.1 Company Overview
10.2.2 Product/Service Landscape
10.2.3 Financial Overview
10.2.4 Recent Developments
10.3 Cepheid, Inc
10.3.1 Company Overview
10.3.2 Product/Service Landscape
10.3.3 Financial Overview
10.3.4 Recent Developments
10.4 Bio-Rad Laboratories, Inc
10.4.1 Company Overview
10.4.2 Product/Service Landscape
10.4.3 Financial Overview
10.4.4 Recent Developments
10.5 Biomatrix
10.5.1 Company Overview
10.5.2 Product/Service Landscape
10.5.3 Financial Overview
10.5.4 Recent Developments
10.6 Becton
10.6.1 Company Overview
10.6.2 Product/Service Landscape
10.6.3 Financial Overview
10.6.4 Recent Developments
10.7 Dickinson and Company
10.7.1 Company Overview
10.7.2 Product/Service Landscape
10.7.3 Financial Overview
10.7.4 Recent Developments
10.8 Hoffmann-La Roche AG
10.8.1 Company Overview
10.8.2 Product/Service Landscape
10.8.3 Financial Overview
10.8.4 Recent Developments
10.9 Bayer HealthCare Pharmaceuticals LLC
10.9.1 Company Overview
10.9.2 Product/Service Landscape
10.9.3 Financial Overview
10.9.4 Recent Developments
The POC Molecular Diagnostics Market has been segmented as below:
POC Molecular Diagnostics Market, By Application
POC Molecular Diagnostics Market, By Technology
POC Molecular Diagnostics Market, By End Use
POC Molecular Diagnostics Market, By Region
POC Molecular Diagnostics Market, By Company
SUBSCRIBE TO OUR NEWSLETTERS
